Clinical trial Recruiting at 2 sites Observational Ages 18 to 79

Sleep problems, fatigue, and thinking ability in people with MS

Official title: The Effects of Sleep Disturbances on Fatigue and Cognition in Multiple Sclerosis

Run by Heinrich-Heine University, Duesseldorf · NCT07426991 · Data updated 2026-11-12

We will try to see if sleep problems explain why adults with MS feel very tired and have trouble thinking.

Quick facts

Study typeObservational
Ages18 Years to 79 Years
SexAll
Enrollment837 (estimated)
SponsorHeinrich-Heine University, Duesseldorf
Academic / other
Drugs / interventionsimmunotherapy, Ocrelizumab
Locations2 sites (Düsseldorf and 1 other locations)
StatusRecruiting
StartedNovember 1, 2024
Main results expectedJanuary 2028
Study endsDecember 2028
Registry record updatedMarch 6, 2026
Trial IDNCT07426991 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–79 with a diagnosis of MS (2017 McDonald criteria), at least mild fatigue (FSMC ≥ 43), adequate hearing/vision, German language proficiency, and capacity to consent are ideal candidates.

Probably not a fit

People outside the 18–79 age range, those with other neurological disorders (except migraine), or those taking medications that alter sleep recordings may not benefit from the study findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort enrolls adults with multiple sclerosis who have at least mild fatigue and compares them with control participants referred for sleep evaluation. Participants undergo overnight polysomnography, standardized questionnaires (including the FSMC), and objective motor and cognitive fatigability testing to link sleep architecture to subjective and objective fatigue and cognitive performance. The study will compare patients with and without sleep-related abnormalities and explore which sleep parameters most strongly correlate with fatigue severity and performance decline. Standard eligibility criteria (age 18–79, German language proficiency, adequate hearing/vision, and no interfering medications or other neurological disorders) are applied.

Why it matters

Potential benefit: If successful, the findings could identify treatable sleep disorders that, when addressed, reduce fatigue and improve thinking and quality of life for people with MS.

How similar studies have gone: Prior research has linked sleep disorders to fatigue and cognitive problems in MS, but few studies used full polysomnography and causal relationships remain unproven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 and ≤ 79 years (all groups)
* Adequate (corrected) hearing and vision to complete neuropsychological testing (all groups)
* Sufficient proficiency in German to participate in assessments (all groups)
* Capacity to provide informed consent and understanding of study procedures (all groups)
* Diagnosis of MS according to the 2017 revised McDonald criteria (MS group)
* Indication for sleep medicine evaluation due to at least mild fatigue, operationalized as ≥ 43 points on the Fatigue Scale for Motor and Cognitive Functions (FSMC) (MS group)
* Indication for sleep medicine evaluation (control group)

Exclusion Criteria:

* Lack of signed informed consent or inability to provide consent (all groups)
* Age \< 18 years or \> 79 years (all groups)
* Presence of another neurological disorder in addition to MS, with the exception of migraine (all groups)
* Use of medications that influence polysomnographic parameters (e.g., benzodiazepines) (all groups)
* Uncorrected hearing or vision impairment and/or insufficient German language proficiency likely to impact neuropsychological test results (all groups)

Where it's running

  • University Hospital Düsseldorf
    Düsseldorf, Germany
    Recruiting
  • Maria Hilf Clinics
    Mönchengladbach, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.